Next-generation diagnostics and therapeutics for cancerINOVIQ Ltd Annual Report 20261 Chairman’s Letter 2 CEO’s Report4 Review of Operations 16 Directors’ Report31 Auditor’s Independence Declaration32 Consolidated Statement of Comprehensive Income33 Consolidated Statement of Financial...
2026 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and Preliminary Financial Report
- Becoming a substantial holder
- EXO-OC Study Outcome Investor Webinar Presentation
- Quarterly Activities Report and Appendix 4C - June 2026
Later from Inoviq
- EXO-OC Technical Review and Commercialisation Pathway
- INOVIQ Announces Leadership Change
- Notice of Annual General Meeting/Proxy Form
- INOVIQ receives $1.782m R&D Tax Incentive Refund
- Quarterly Activities Report and Appendix 4C - September 2026
